carbidopa has been researched along with Body Weight in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Balogun, CI; Fatoki, AM; Oladimeji, S; Olofinnade, AT; Onaolapo, AY; Onaolapo, OJ; Onaolapo, TM | 1 |
| Khurana, N; Muthuraman, A; Sharma, N; Utreja, P | 1 |
| Armstrong, D; Courtney, CL; Palfai, T | 1 |
| Bender, DA | 1 |
| Gerdes, U; Lehmann, K; Ulm, G | 1 |
| Kemi, M; Kondo, M; Maki, E; Tanabe, K | 1 |
| Bandini, LG; Fukagawa, NK; Lee, MA; Young, JB | 1 |
| Jenner, P; Marsden, CD; Rose, S | 1 |
| Sakajiri, K; Takamori, M | 1 |
| Barbieri, S; Bevilacqua, M; Lanfredini, M; Micossi, P; Nitti, F; Norbiato, G; Raggi, U | 1 |
| Dulka, JG; Peter, RE; Sloley, BD; Trudeau, VL | 1 |
| Blunt, S; Jenner, P; Marsden, CD | 1 |
| Hayashi, M; Kitajima, W; Saruta, T; Yamaji, Y | 1 |
| Löscher, W; Pagliusi, SR | 1 |
14 other study(ies) available for carbidopa and Body Weight
| Article | Year |
|---|---|
An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice.
Topics: Animals; Antioxidants; Antiparkinson Agents; Antipsychotic Agents; Behavior, Animal; Body Weight; Carbidopa; Chlorpromazine; Diet; Drug Combinations; Eating; Grooming; Levodopa; Lipid Peroxidation; Mice; Motor Activity; Parkinson Disease, Secondary; Pyridoxal Phosphate | 2020 |
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model.
Topics: Animals; Antioxidants; Antiparkinson Agents; Behavior, Animal; Body Weight; Carbidopa; Catalase; Catalepsy; Disease Models, Animal; Dopamine; Drug Combinations; Female; Glutathione; Levodopa; Locomotion; Male; Mesencephalon; Muscular Diseases; Oxidative Stress; Parkinson Disease; Postural Balance; Rats, Sprague-Dawley; Rotenone; Superoxides; Thiobarbituric Acid Reactive Substances; Vanillic Acid | 2021 |
Effect of l-dopa or bromocriptine on feeding and motor behavior of rats with lesions in the globus pallidus.
Topics: Animals; Body Weight; Brain Mapping; Bromocriptine; Carbidopa; Drinking; Eating; Globus Pallidus; Hydroxydopamines; Levodopa; Male; Motor Activity; Neural Pathways; Oxidopamine; Rats; Receptors, Dopamine; Sex Factors | 1984 |
Effects of benserazide, carbidopa and isoniazid administration on tryptophan-nicotinamide nucleotide metabolism in the rat.
Topics: Animals; Benserazide; Body Weight; Carbidopa; Diet; Hydrazines; Isoniazid; Liver; Male; Niacinamide; Rats; Ribonucleotides; Time Factors; Tryptophan | 1980 |
Response to Sinemet 25/100 in Parkinson's disease.
Topics: Aged; Benserazide; Body Weight; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors | 1984 |
Influence of carbidopa, an aromatic amino acid decarboxylase inhibitor, on the development of autoimmune hemolytic anemia in NZB mice.
Topics: Anemia, Hemolytic, Autoimmune; Animals; Body Weight; Carbidopa; Coombs Test; Female; Hematocrit; Levodopa; Male; Methyldopa; Mice; Mice, Inbred NZB | 1983 |
Effect of age on dopaminergic responses to protein feeding.
Topics: Adult; Aged; Aging; Amines; Amino Acids; Blood Pressure; Body Weight; Carbidopa; Creatinine; Diet, Sodium-Restricted; Dietary Proteins; Diuresis; Dopamine; Hormones; Humans; Male; Natriuresis; p-Aminohippuric Acid; Pulse | 1995 |
Chronic administration does not alter the pharmacokinetic profile of L-dopa in the rat.
Topics: Administration, Oral; Animals; Body Weight; Carbidopa; Dopa Decarboxylase; Drug Administration Schedule; Injections, Intra-Arterial; Levodopa; Liver; Male; Rats; Rats, Wistar; Time Factors | 1993 |
[Body fat loss in patients with Parkinson's disease].
Topics: Adipose Tissue; Aged; Aged, 80 and over; Antiparkinson Agents; Body Mass Index; Body Weight; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1997 |
Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa.
Topics: Adult; Aldosterone; Body Weight; Carbidopa; Edema; Female; Humans; Hydrazines; Levodopa; Metoclopramide; Renin; Sodium | 1979 |
Selective depletion of dopamine in the goldfish pituitary caused by domperidone.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Benzazepines; Body Weight; Brain Chemistry; Carbidopa; DOM 2,5-Dimethoxy-4-Methylamphetamine; Domperidone; Dopamine; Dose-Response Relationship, Drug; Female; Goldfish; Gonadotropins; Hypothalamus; Male; Methyltyrosines; Mice; Norepinephrine; Pituitary Gland; Receptors, Dopamine; Serotonin; Telencephalon; Tyrosine 3-Monooxygenase | 1991 |
The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
Topics: Animals; Apomorphine; Body Weight; Carbidopa; Corpus Striatum; Drinking; Female; Fetal Tissue Transplantation; Hydroxydopamines; Levodopa; Mesencephalon; Motor Activity; Nervous System; Oxidopamine; Parkinson Disease; Rats; Rotation; Stereotyped Behavior; Time Factors | 1991 |
Effects of high salt intake on dopamine production in rat kidney.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Blood Pressure; Body Weight; Carbidopa; Denervation; Dopamine; Inulin; Kidney; Levodopa; Male; Rats; Rats, Inbred Strains; Reference Values; Sodium, Dietary | 1991 |
Development of tolerance to the wet-dog shake behaviour but not the increase in seizure threshold induced by L-5-hydroxytryptophan during continued treatment in rats.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Body Weight; Brain Chemistry; Carbidopa; Drug Interactions; Drug Tolerance; Female; Hydroxyindoleacetic Acid; Movement Disorders; Rats; Rats, Inbred Strains; Seizures; Serotonin | 1985 |